新型冠状病毒肺炎疫情防控期间疟疾患者血样检测的思考和建议

Consideration and recommendations for malaria blood testing during the COVID-19 pandemic

目前全球新型冠状病毒肺炎(COVID-19)疫情不断蔓延,自境外疟疾流行区入境人员存在疟原虫及新型冠状病毒(SARS-CoV-2)双重感染风险,为及时、准确、安全地开展疟疾检测,保障输入性疟疾的早发现、早诊断和早治疗,笔者提出在COVID-19疫情防控期间,疟疾患者血样检测工作中需提高生物安全防护级别、优先采用快速诊断检测(RDT)和核酸检测方法、至少两种检测方法结果一致作为虫种确认依据、实施血片特殊制备的方法等建议,供各临床和疾控实验室参考。

With the ongoing global spread of coronavirus disease 2019(COVID-19) epidemic,there is a risk of co-occurrence of malaria and COVID-19 in people returning from malaria-endemic areas abroad.In order to conduct timely,accurate and safe detection of malaria cases,ensuring early finding,diagnosis and treatment of imported malaria,we propose that facing the current pandemic situation,higher level of biosafety protective practice is needed for handling malaria blood samples with potential risk,use of rapid diagnostic test and nuclear acid detection method is the first choice,confirmation of Plasmodium species should be made based on consistency between at least two detection methods,and blood smears should be prepared with special procedures when necessary.